Foundation directory
Zoll Foundation Inc Grants
Private foundation · EIN 46-3630772 · IRS 990-PF filings through tax year 2024
- Total grants paid
- $2.9M
- Grants reported
- 58
- Median grant
- $49.9K
- Future commitments
- None reported
Giving by tax year
| Tax year | Grants paid | Amount |
|---|---|---|
| 2024 | 23 | $1.3M |
| 2023 | 35 | $1.6M |
Where Zoll Foundation Inc gives
States of grant recipients reported on the foundation's 990-PF filings, by dollars received.
Largest reported grants
The biggest individual grants on file, as reported by the foundation to the IRS.
| Recipient | Location | Purpose | Tax year | Amount |
|---|---|---|---|---|
| CHILDREN'S NATIONAL HOSPITAL | NM WASHINGTON, DC | DR. TON - MECHANISM OF SELECTIVE VULNERABILITY IN THE THALAMIC RETICULAR NUCLEUS AFTER CARDIAC ARREST | 2023 | $100K |
| MURDOCH CHILDREN'S RESEARCH INSTITUTE | MELBOURNE | DR. FERGUSON - RESEARCH FOR LOWER GAS FLOWS DURING RESPIRATORY SUPPORT FOR EXTREMELY PRETERM INFANTS | 2024 | $93.7K |
| GOVERNORS OF THE UNIVERSITY OF ALBERTA | EDMONTON | DR. MORIN - RESEARCH FOR IMPROVING CARDIOPULMONARY RESUSCITATION AND SURVIVAL IN CHILDREN FOLLOWING DROWNING | 2024 | $89.1K |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | NEW YORK, NY | DR. OWYANG VA-ECMO-SUPPORT - THE EFFECT OF PEEP ON RV FUNCTION IN ECPR: A PRE-CLINICAL SWINE MODEL | 2023 | $85.7K |
| THE GENERAL HOSPITAL CORPORATION | BOSTON, MA | DR. MERETO - RESEARCH FOR DELIVERY OF HIGH-DOSE NITRIC OXIDE THROUGH STANDARD EMCO IN A SWINE MODEL TO FIGHT THE WORLDWIDE MULTI-DRUG RESISTANT PATHOGENS EMERGENCY IN CRITICALLY ILL PATIENTS | 2024 | $85.3K |
| BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON, MA | DR. KRAVITZ - FRESH FROZEN PLASMA TREATMENT FOR GLYCOCALYX DEGRADATION IN SEPSIS | 2024 | $84.9K |
| BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON, MA | DR. LEE - MONITORING PULMONARY EDEMA IN MECHANICALLY VENTILATED PATIENTS USING WEARABLE STETHOSCOPES | 2024 | $84.2K |
| HEIDELBERG UNIVERSITY HOSPITAL | HEIDELBERG | DR. KATZENSCHLAGER - DOUBLE SEQUENTIAL EXTERNAL DEFIBRILLATION IN REFRACTORY VENTRICULAR FIBRILLATION - D.10054715 KATZENSCHLAGER TRIAL, A MULTICENTRIC CLUSTER RANDOMIZED STUDY | 2024 | $82K |
| CHARITE - UNIVERSITATSMEDIZIN BERLIN | BERLIN | DR ENDISCH RESEARCH QUANTIFICATION OF SEVERITY OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN POSTMORTEM BRAIN AUTOPSY TO IMPROVE NEUROPROGNOSTICATION AND TEMPERATURE CONTROL AFTER CARDIAC ARREST | 2023 | $80K |
| DARTMOUTH-HITCHCOCK CLINIC | LEBANON, NH | DR. ERIC ROTHSTEIN - RATE OPTIMIZATION OF THE VEST CPR-T COMPREHENSIVE CARDIAC ARREST RECOVERY SYSTEM UTILIZING A PORCINE VENTRICULAR FIBRILLATION MODEL | 2024 | $77.9K |
| ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE | NORTH CHICAGO, IL | DR. RAZI - SELECTIVE TARGETING OF PERIPHERAL A2-ADRENOCEPTORS WITH A-METHYLNOREPINEPHRINE AS A SUPERIOR ALTERNATIVE TO EPINEPHRINE FOR RESUSCITATION FROM CARDIAC ARREST | 2024 | $64.9K |
| OSLO UNIVERSITY HOSPITAL | OSLO | DR. SVENSOY - HEMODYNAMICS AND HYPOXIC ORGAN DAMAGE DURING CARDIOPULMONARY RESUSCITATION WITH INFLATED AORTIC BALLOON CATHETER IN COMBINATION WITH INFUSION OF ORGAN PRESERVATION SOLUTION IN A PIG MODEL OF CARDIAC ARREST | 2023 | $61K |
| THE GENERAL HOSPITAL CORPORATION | BOSTON, MA | DR. OKDA - REDUCING THE BURDEN OF MRSA PNEUMONIA IN POST CARDIAC ARREST PATIENTS USING HIGH DOSE INHALED NO IN AN EXPERIMENTAL SWINE MODEL A SYSTEMATIC SCOPING REVIEW OF INTERNATIONAL UNCONTROLLED DONATION AFTER CARDIAC DEATH (UDCD PRACTICES AFTER OUT-OF-HOSPITAL CARDIAC ARREST | 2023 | $60.7K |
| THE MEDICAL UNIVERSITY OF VIENNA AUSTRIA | WIEN | DR. HILLEBRAND - THE USE OF EXTRACORPOREAL PHOTOPHERESIS AS IMMUNOMODULATORY THERAPY OF SUBCLINICAL ANTIBODY-MEDICATED REJECTION AFTER LUNG TRANSPLANTATION: A PROSPECTIVE RCT | 2024 | $60K |
| MAYO CLINIC | ROCHESTER, MN | DR HYDE RESEARCH PHYSIOLOGIC TARGETS FOR PULSELESS ELECTRICAL ACTIVITY | 2023 | $57.8K |
| MURDOCH CHILDREN'S RESEARCH INSTITUTE | MELBOURNE | DR. TURNER - RESEARCH FOR DECODING RHINOVIRUS PNEUMONIA: HOST DEPENDENCIES AND ABERRANT INFLAMMATION IN THE ALVEOLUS | 2024 | $56.3K |
| HIROSHIMA UNIVERSITY | HIGASHIHIROSHIMA, HIROSHIMA | DR. NISHIKIMI RESEARCH SELECTIVE BRAIN HYPOTHERMIA COMBINED WITH CORE WARMING WITH AN ENDOVASCULAR DEVICES | 2023 | $55K |
| ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE | NORTH CHICAGO, IL | DR. SAEED - OPTIMIZING THE HEMODYNAMIC MANAGEMENT OF SEPTIC SHOCK BY CONTINUOUS MONITORING OF MICROCIRCULATORY PARAMETERS | 2024 | $54.1K |
| ANTWERP UNIVERSITY HOSPITAL | EDEGEM | DR VERDONCK RESEARCH INJURY-SPECIFIC DIFFERENCES IN THE ADAMTS13-VWF AXIS IN MAJOR TRAUMA PATIENTS | 2023 | $51.6K |
| MAYO CLINIC | ROCHESTER, MN | DR. WIERUSZEWSKI - RESEARCH INTO EVALUATION OF PLASMA RENIN CONCENTRATIONS IN CARDIAC SURGERY | 2024 | $50K |
| BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | DR. LEVY - ACTIVATION OF TISSUE-RESIDENT STEM CELLS DURING ACUTE BURN TRAUMA CARE | 2023 | $50K |
| UNITY HEALTH TORONTO | TORONTO, ONTARIO | DR NOLAN RESEARCH A PROSPECTIVE OBSERVATIONAL STUDY OF SAFETY THREATS AND ADVERSE EVENTS IN TRAUMA (PRO-STAT) | 2023 | $50K |
| THE FEINSTEIN INSTITUTE | MANHASSET, NY | DR. TAMBO, DR. CHUNYAN LI RESEARCH APPLICATION OF DIVING REFLEX IN A PORCINE MODEL OF ACUTE SHOCK | 2023 | $50K |
| THE GRADUATE SCHOOL OF NIPPON SPORT SCIENCE UNIVERSITY | SETAGAYAKU, TOKYO | MS. TAKAHASHI - SUSTAINABLE EMERGENCY MEDICAL SYSTEMS AND RESUSCITATION STRATEGIES IN DEVELOPING COUNTRIES | 2023 | $50K |
| THE FEINSTEIN INSTITUTE | MANHASSET, NY | MR BIELAWA - ENTITLED "DETECTING RETURN OF SPONTANEOUS CIRCULATION USING FEMORAL ARTERIAL DOPPLER WAVEFORMS DURING CHEST COMPRESSIONS" | 2023 | $49.9K |
How to apply
This foundation reports on its 990-PF that it only makes contributions to preselected organizations and does not accept unsolicited applications.
About this data
Figures are aggregated from Zoll Foundation Inc's IRS Form 990-PF electronic filings (2 filings on file, most recent tax year 2024). Totals reflect grants the foundation reported as paid, and can lag the current year because foundations file annually and often on extension. Source: IRS 990-PF e-file archive.